BIMI International Medical Inc. Common Stock
BIMI
BIMI was delisted on the 21st of August, 2024.
3 hedge funds and large institutions have $19K invested in BIMI International Medical Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
19% more capital invested
Capital invested by funds: $16K → $19K (+$3K)
0% more funds holding
Funds holding: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$11.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$641 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$49 |
BIMI Hedge Fund Activity: Q4 2015 in Review
3 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in BIMI International Medical Inc. Common Stock (BIMI) for Q4 2015, worth a combined $19K — up 19% from $16K a quarter earlier.
Fund positioning in BIMI was balanced in Q4 2015: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $11.4K. The largest seller was Tower Research Capital (TRC), cutting an estimated $49.
- 3 institutional investors held BIMI International Medical Inc. Common Stock (BIMI) as of Q4 2015, unchanged from Q3 2015.
- Funds reported $19K of BIMI International Medical Inc. Common Stock stock for Q4 2015, up 19% quarter-over-quarter.
- 0 funds opened new BIMI International Medical Inc. Common Stock positions in Q4 2015 and 0 closed out.
- The largest BIMI International Medical Inc. Common Stock buyer in Q4 2015 was Citadel Advisors, an estimated $11.4K added.
- The largest BIMI International Medical Inc. Common Stock seller in Q4 2015 was Tower Research Capital (TRC), an estimated $49 sold.
Based on aggregated 13F filings for Q4 2015.